Myasthenia Gravis Complicated with Primary Aldosteronism and Hypokalemic Myopathy

Total Page:16

File Type:pdf, Size:1020Kb

Myasthenia Gravis Complicated with Primary Aldosteronism and Hypokalemic Myopathy □ CASE REPORT □ Myasthenia Gravis Complicated with Primary Aldosteronism and Hypokalemic Myopathy Shu-ichi Yamashita, Wakaba Tsuchimochi, Tadato Yonekawa, Hideki Yamaguchi, Itaru Kyoraku, Kazutaka Shiomi and Masamitsu Nakazato Abstract A 34-year-old Japanese man was admitted to an outside hospital with an elevated creatinine kinase level and suspected myositis. He was treated with high dose methylprednisolone, which caused severe aggravation of muscle weakness. He was transferred to our hospital at that time. On admission, chest computed tomogra- phy (CT) and the presence of anti-acetylcholine receptor antibodies supported a diagnosis of myasthenia gra- vis and thymoma. Laboratory findings showed hypokalemia, low plasma renin activity and high serum al- dosterone. Further studies, including abdominal CT and adrenal venous sampling suggested primary al- dosteronism. At first, thymectomy was performed, and one month later, he was treated with laparoscopic adrenalectomy. Immediately after this procedure, he suffered from myasthenic crisis, which was successfully managed with mechanical ventilation and steroid pulse therapy followed by oral prednisolone. This case pre- sented a serious difficulty in differentiating from various myopathies and giving proper treatment because of a rare combination of independent diseases and their masquerading clinical features. Key words: myasthenic crisis, hypokalemia, thymectomy, adrenalectomy, hypokalemia-induced rhabdomy- olysis (Inter Med 48: 1465-1469, 2009) (DOI: 10.2169/internalmedicine.48.2311) mary aldosteronism. At first, he was considered to have Introduction myositis and was treated as such at his former hospital based on the high titer of creatinine kinase due to Myasthenic crisis is one of the most critical complications hypokalemia-induced rhabdomyolysis. of myasthenia gravis (MG). When a patient of MG shows an acute aggravation of muscle weakness, we have to con- Case Report sider the status of the condition and treat it immediately (1, 2). However, there remains the possibility that other disease A 34-year-old Japanese man was admitted to an outside entities happen to complicate it, rendering only slight differ- hospital with dropped head syndrome, limb muscle weak- ences in intricate clinical features. ness and dyspnea, which progressed sub-acutely over the The clinical characteristics of primary aldosteronism are course of 20 days prior to admission. Serum chemistry data treatment-resistant hypertension, hypokalemia, suppressed showed the elevation of creatinine kinase (CK) level (1,048 plasma renin activity and excessive aldosterone production. IU/L). Despite his low serum potassium level (3.1 mEq/L), Sometimes it can cause rhabdomyolysis due to severe hy- he was treated with a three-day course of 1.5 g/day methyl- pokalemia (3-5). If this condition supervenes MG, muscle prednisolone because the presence of myositis was sus- weakness can deteriorate and its clinical features become pected. After the treatment, his symptoms transiently confusing, which should be differentiated from myasthenic showed marked deterioration and then slightly improved af- crisis. Here, we present a case of MG complicated with pri- ter the treatment. He also started to suffer from dysphagia. Neurology, Respirology, Endocrinology and Metabolism, Dapartment of Internal Medicine, Faculty of Medicine, University of Miyazaki, Mi- yazaki Received for publication March 30, 2009; Accepted for publication May 10, 2009 Correspondence to Dr. Shu-ichi Yamashita, [email protected] 1465 Inter Med 48: 1465-1469, 2009 DOI: 10.2169/internalmedicine.48.2311 He had no complaint of diplopia. He was transferred to our showed a left adrenal small mass without enhancement hospital. Physical examination on admission revealed (Fig. 2). Subsequently, adrenal venous sampling was per- marked obesity (BMI 35.7), a blood pressure of 144/86 formed. The ratio of aldosterone/cortisol in the blood from mmHg on anti-hypertensive medications and pulse rate of the left adrenal vein was much higher than that of the right 98/min, and mild bilateral blepharoptosis that worsened after adrenal vein (Fig. 3) (6). The diagnosis of MG with thy- a sustained upward gaze for 45 seconds. The proximal mus- moma complicated with primary aldosteronism was made. cles of both upper and lower limbs showed marked weak- Because high dose methylprednisolone could have aggra- ness with easy fatigabilty. Gowers’ sign was positive. The vated the high serum CK level (1,048 mEq/L) and low po- distal muscle groups were relatively spared. There was no tassium level (3.1 mEq/L) on admission to his former hospi- muscle tenderness. An edrophonium test showed transient tal, the acute deterioration of muscle power after steroid improvement of both blepharoptosis and muscle power. An pulse therapy was likely secondary to hypokalemia-induced abnormal decremental compound muscle action potential in rhabdomyolysis. the abductor digiti minimi of approximately 30% was ob- Oral administration of spironolactone was initiated imme- served in the repetitive nerve-stimulation test. Although diately, and oral and intravenous potassium supplementation laboratory findings showed severe hypokalemia (2.6 mEq/ was continued. After normalization of serum potassium, the L), the CK level was already normal (109 IU/L). Serum so- patient felt slight but definite improvement in muscle dium was 145 mEq/L, and immunologic test revealed the strength. Once stabilized, he underwent a thoracotomy for presence of acetylcholine receptor-binding antibodies (Ta- excision of the thymoma, which did not invade the wall of ble 1). Despite administration of oral and intravenous potas- aortic arch and was completely resected. Tissue specimens sium, the patient’s hypokalemia did not improve, and hor- showed an admixture of polygonal epithelial cells without monal test showed suppressed plasma renin activity and ex- apparent cellular atypia or high miotic activity, which was cessive aldosterone production (Table 1). No inflammation compatible with thymoma, type B2 by the classification of was detected in bilateral quadriceps muscles by fat- World Health Organization. After the operation, the patient’s suppressed T2-weighted magnetic resonance imaging. Com- condition including his limb weakness, dyspnea and puted tomography (CT) of the chest demonstrated an ante- dysphagia improved markedly without prednisolone. Then, rior mediastinal mass (Fig. 1). Additionally, abdominal CT he underwent laparoscopic adrenalectomy one month after the thymectomy. However, in the immediate post-operative period, the patient showed dramatic deterioration of his Table 1. Autoantibody and Endocrine Data symptoms (Fig. 4). He also suffered from severe dyspnea. It was difficult for him to swallow his saliva. His arterial blood gas showed pH 7.31, PO2 49.1 mmHg and PCO2 62.3 mmHg. Both serum CK and potassium levels remained within normal limits (102 IU/L and 3.8 mEq/L, respec- tively). There was a transient increase in vital capacity from 300 mL to 600 mL following an edrophonium test, and the patient was immediately intubated and mechanically venti- lated. Treatment with 1.0 g/day of methylprednisolone for three days was started, and this was followed by 60 mg of Figure 1. Axial (A) and coronal (B) views of plain computed tomography (CT) of the chest dem onstrate an anterior mediastinal mass (arrow). 1466 Inter Med 48: 1465-1469, 2009 DOI: 10.2169/internalmedicine.48.2311 Figure 2. Axial (A) and coronal (B) views of abdominal enhanced CT show a left adrenal small mass (arrow) without apparent enhancement. Figure 3. Plasma aldosterone and cortisol concentrations were measured with adrenal venous sampling. There was excessive secretion of aldosterone from the left adrenal gland. Figure 4. Clinical course after admission to our hospital. 1467 Inter Med 48: 1465-1469, 2009 DOI: 10.2169/internalmedicine.48.2311 prednisolone. His condition rapidly improved and mechani- of primary aldosteronism because of the continuation of hy- cal ventilation was discontinued after a few days. Oral pred- pertension and hypokalemia in spite of proper medications nisolone was tapered to a maintenance dose of 10 mg/day (3-5). Hypokalemia in patients with primary aldosteronism within two weeks. On this regimen, his symptoms including can cause muscle weakness. Furthermore, it can induce dropped head syndrome and generalized muscle weakness rhabdomyolysis by enhancing the muscle sodium-potassium resolved, and he was able to climb stairs without any aid. pump activity thereby causing an increase of potassium en- He was on ordinary diet, because there was no dysphagia try into cells. Impaired potassium release from skeletal mus- and his speech was normal. Pathological examination of the cle cells may promote muscle injury or rhabdomyolysis as a left adrenal mass confirmed the presence of a cortical ade- consequence of ischemia due to hypokalemia-induced de- noma. The patient was discharged to his former hospital. crease of blood flow (12, 13). Subsequently, the serum CK level could rise, completing the clinical features of this rare Discussion and complex presentation of diseases of this patient. The decision about which tumor should be operated on It might not have been difficult to diagnose this patient’s first must be a disputable problem. As far as we searched, MG because of the presence of relatively typical clinical we could not identify any published reports on a patient findings such as ptosis and easy fatigability of muscles (7). who had
Recommended publications
  • Code Procedure Description Adrenalectomy 60540 Adrenalectomy, Partial Or Complete, Or Exploration of Adrenal Gland with Or Witho
    BCBSM Approved POP Procedures Code Procedure Description Adrenalectomy Adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar or dorsal 60540 (separate procedure) 60545 Adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, transabdominal, lumbar or dorsal (separate procedure); with excision of adjacent retroperitoneal tumor Laparoscopy, surgical, with adrenalectomy, partial or complete, or exploration of adrenal gland with or without biopsy, 60650 transabdominal, lumbar or dorsal Appendectomy 44955 Appendectomy; when done for indicated purpose at time of other major procedure (not as separate procedure) 44960 Appendectomy; for ruptured appendix with abscess or generalized peritonitis 44970 Laparoscopy, surgical, appendectomy Carotid Endarterectomy (CEA) 35301 Thromboendarterectomy, including patch graft, if performed; carotid, vertebral, subclavian, by neck incision Carpal Tunnel 29848 Endoscopy, wrist, surgical, with release of transverse carpal ligament 64721 Neuroplasty and/or transposition; median nerve at carpal tunnel Cesarean Delivery (Cesarean Section) Ligation or transection of fallopian tube(s) when done at the time of cesarean delivery or intra-abdominal surgery (not a separate 58611 procedure) (List separately in addition to code for primary procedure) 59510 Routine obstetric care including antepartum care, cesarean delivery, and postpartum care 59514 Cesarean delivery only 59515 Cesarean delivery only; including postpartum care
    [Show full text]
  • Adrenalectomy Patient Information Leaflet
    Adrenalectomy Patient information leaflet UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm What is an adrenalectomy? An adrenalectomy (ad-renal-ect-omy) is an operation to remove one or both of the adrenal glands. The adrenal glands sit above the kidneys. Right Left adrenal adrenal gland gland Kidney Kidney The main role of the adrenal glands is to release hormones into the body. The main hormones released are stress related hormones (cortisol, noradrenaline and adrenaline), hormones that regulate metabolism, hormones that affect immune system function, androgens (sex hormones) and hormones for saltwater balance (aldosterone). 2 | PI18/1289/03 Adrenalectomy An adrenalectomy can be done: • ‘Open’ with one large surgical cut below the ribcage • Or ‘laparoscopic’ which involves four smaller cuts being made allowing the inside of the abdomen to be seen using a camera Some laparoscopic operations may have be converted to ‘open’ at the time of the surgery due to the surgeon not being able to see the inside of the abdomen clearly enough (about 5% of cases). The surgery is performed under general anaesthetic so you will be asleep and will not feel any pain. The surgery normally takes 1–2 hours. The adrenal gland(s) will be sent to a pathologist after it is removed for further tests in a laboratory using a microscope. Why is an adrenalectomy performed? The adrenal gland(s) need to be removed if there is a mass/ tumour in the gland(s). An adrenalectomy is performed if: 1.
    [Show full text]
  • Pseudoischemic Electrocardiogram in Myasthenia Gravis with Thymoma Published Online in Wiley Interscience
    Address for correspondence: Nicola Mumoli, MD CaseShort Communication Livorno Hospital Department of Internal Medicine Viale Alfieri 36 Pseudoischemic Electrocardiogram in 57100 Livorno, Italy Myasthenia Gravis with Thymoma: [email protected] Reversibility After Thymectomy Patrizio Chiavistelli, MD, Marco Cei, MD, Giovanni Carmignani, MD, Carlo Bartolomei, MD Nicola Mumoli, MD Department of Internal Medicine, Livorno Hospital, Livorno, Italy Abnormal ST T-wave changes can be found at presentation in various noncoronary disorders; misinterpretation of these patterns as ischemic heart disease can lead to erroneous diagnosis and treatment. Here we present a case of myasthenia gravis (MG) with thymoma, in which the resting electrocardiogram (ECG) led to a misleading diagnosis of myocardial ischemia. After thymectomy, the ECG resumed a normal pattern. Myasthenia gravis is not usually considered in the differential diagnosis of conditions associated with an abnormal ECG. The combination of dysphagia, dyspnoea, ECG changes, and creatine kinase (CK) elevations may easily bring to mind an erroneous and possibly deleterious diagnosis of myocardial ischemia. Introduction did not seek medical attention. At the beginning of the The resting 12-lead electrocardiogram (ECG) remains at current year, he reported a flu-like illness, with spontaneous the center of the diagnostic pathways of acute coronary recovery, but shortly afterward he experienced dyspnea, syndromes (ACSs), either with1 or without ST segment dysphagia, and weight loss (37 kg). One month before elevation,2 because it serves as an invaluable tool for admission, he underwent fiberoptic endoscopy of the nose, both diagnosis and risk stratification. Nevertheless, as is pharynx, and larynx because of dysphonia, without any universally accepted, the predictive value of any diagnostic evidence of an active disease.
    [Show full text]
  • Advances in Risk-Oriented Surgery for Multiple Endocrine Neoplasia Type 2
    25 2 Endocrine-Related A Machens et al. Advances in risk-oriented 25:2 T41–T52 Cancer surgery for MEN2 THEMATIC REVIEW Advances in risk-oriented surgery for multiple endocrine neoplasia type 2 Andreas Machens1 and Henning Dralle2 1Department of General, Visceral and Vascular Surgery, Martin Luther University Halle-Wittenberg, Halle, Saale, Germany 2Department of General, Visceral and Transplantation Surgery, Section of Endocrine Surgery, University of Duisburg-Essen, Essen, Germany Correspondence should be addressed to A Machens: [email protected] This paper is part of a thematic review section on 25 Years of RET and MEN2. The guest editors for this section were Lois Mulligan and Frank Weber. Abstract Genetic association studies hinge on definite clinical case definitions of the disease of Key Words interest. This is why more penetrant mutations were overrepresented in early multiple f biochemical screening endocrine neoplasia type 2 (MEN2) studies, whereas less penetrant mutations went f DNA-based screening underrepresented. Enrichment of genetic association studies with advanced disease f RET proto-oncogene may produce a flawed understanding of disease evolution, precipitating far-reaching f gene test surgical strategies like bilateral total adrenalectomy and 4-gland parathyroidectomy in f gene carrier MEN2. The insight into the natural course of the disease gleaned over the past 25 years f multiple endocrine caused a paradigm shift in MEN2: from the removal of target organs at the expense of neoplasia type 2A greater operative
    [Show full text]
  • Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist
    [CANCER RESEARCH 26 Part I, 551-574, April 1966] Studies of Thymic Function with Emphasis on the Role of the Thymus in Oncogenesist LLOYDW. LAW National Cancer Institute, Bethesda, Maryland This presentation will be concerned with 2 general topics: organ to other sites occurs with a selective seeding in spleen (a) our present knowledge of thymic structure and function, lymph nodes, and other lymphoid organs. but particularly the latter, as revealed by the results of recent For a more detailed discussion of the ontogeny of the thymus experiments in several species of animals following early thymic and its microscopic anatomy, the reader is referred to the studies ablation, and (b) consideration of the precise role of the thymus in of Smith (97) and of Ruth et al. (92). the initiation and suppression of neoplastic growths. Pertaining to Thymic Structure and Function Origin and Early Structure of the Thymus In most species the thymus is located in the upper anterior The thymus is a compound organ consisting of 3 quite different part of the chest. Exceptions are the chicken and guinea pig. cell systems: (a) lymphoid cells, (b) reticulum cells, and (c) The absolute size varies from species to species but the absolute e[)ithehal cells. The latter 2 may be referred to as the epithelial size of thymic lobules appears to be remarkably uniform in the reticulum cell complex. The thymus in mammals arises as various species, suggesting that there may be a critical limit for paired structures from the endoderm of the 3rd and 4th branchial the size of a thymic lobule.
    [Show full text]
  • Analysis of the Role of Thyroidectomy and Thymectomy in the Surgical Treatment of Secondary Hyperparathyroidism
    Am J Otolaryngol 40 (2019) 67–69 Contents lists available at ScienceDirect Am J Otolaryngol journal homepage: www.elsevier.com/locate/amjoto Analysis of the role of thyroidectomy and thymectomy in the surgical ☆ treatment of secondary hyperparathyroidism T Mateus R. Soares, Graziela V. Cavalcanti, Ricardo Iwakura, Leandro J. Lucca, Elen A. Romão, ⁎ Luiz C. Conti de Freitas Division of Head and Neck Surgery, Department of Ophthalmology, Otolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School, University of Sao Paulo, Brazil ARTICLE INFO ABSTRACT Keywords: Purpose: Parathyroidectomy can be subtotal or total with an autograft for the treatment of renal hyperpar- Parathyroidectomy athyroidism. In both cases, it may be extended with bilateral thymectomy and total or partial thyroidectomy. Hyperparathyroidism Thymectomy may be recommended in combination with parathyroidectomy in order to prevent mediastinal Thymectomy recurrence. Also, the occurrence of thyroid disease observed in patients with hyperparathyroidism is poorly Thyroidectomy understood and the incidence of cancer is controversial. The aim of the present study was to report the ex- perience of a single center in the surgical treatment of renal hyperparathyroidism and to analyse the role of thyroid and thymus surgery in association with parathyroidectomy. Materials and methods: We analysed parathyroid surgery data, considering patient demographics, such as age and gender, and surgical procedure data, such as type of hyperparathyroidism, associated thyroid or thymus surgery, surgical duration and mediastinal recurrence. Histopathological results of thyroid and thymus samples were also analysed. Results: Medical records of 109 patients who underwent parathyroidectomy for secondary hyperparathyroidism were reviewed. On average, thymectomy did not have impact on time of parathyroidectomy (p = 0.62) even when thyroidectomy was included (p = 0.91).
    [Show full text]
  • Use of Dexmedetomidine in a Parturient with Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy
    PRACTICE CASE REPORT Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report Amanda L. Faulkner, MD, Eric Swanson, MD, Thomas L. McLarney, MD, Cortney Y. Lee, MD, and Annette Rebel, MD * * * † * 08/15/2018 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3yRlXg5VZA8uqNuqWFo8dRhJiNZRTFLkCeIa0nEMHM2KbYm37VRaE3A== by https://journals.lww.com/aacr from Downloaded Dexmedetomidine is a selective α2-agonist, frequently used in perioperative medicine as anes- thesia adjunct. The medication carries a Food and Drug Administration pregnancy category C Downloaded designation and is therefore rarely used for parturients undergoing nonobstetric surgery. We are reporting the use of dexmedetomidine in the anesthetic management of a parturient undergoing minimally invasive unilateral adrenalectomy for pheochromocytoma during the second trimester from https://journals.lww.com/aacr of pregnancy. Additionally, because of the multiple endocrine neoplasia type 2A constellation with diagnosis of medullary thyroid cancer, the patient underwent a total thyroidectomy 1 week after the adrenalectomy. (A&A Practice. XXX;XXX:00–00.) exmedetomidine is a selective α2-agonist, fre- CASE REPORT by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3yRlXg5VZA8uqNuqWFo8dRhJiNZRTFLkCeIa0nEMHM2KbYm37VRaE3A== quently used in perioperative medicine. It has A 34-year-old gravida 3 para 2 woman (body weight, 61 Dfound favor in this setting because of its sedative kg;
    [Show full text]
  • Surgical Indications and Techniques for Adrenalectomy Review
    THE MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL DOI: 10.14744/SEMB.2019.05578 Med Bull Sisli Etfal Hosp 2020;54(1):8–22 Review Surgical Indications and Techniques for Adrenalectomy Mehmet Uludağ,1 Nurcihan Aygün,1 Adnan İşgör2 1Department of General Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey 2Department of General Surgery, Bahcesehir University Faculty of Medicine, Istanbul, Turkey Abstract Indications for adrenalectomy are malignancy suspicion or malignant tumors, non-functional tumors with the risk of malignancy and functional adrenal tumors. Regardless of the size of functional tumors, they have surgical indications. The hormone-secreting adrenal tumors in which adrenalectomy is indicated are as follows: Cushing’s syndrome, arises from hypersecretion of glucocorticoids produced in fasciculata adrenal cortex, Conn’s syndrome, arises from an hypersecretion of aldosterone produced by glomerulosa adrenal cortex, and Pheochromocytomas that arise from adrenal medulla and produce catecholamines. Sometimes, bilateral adre- nalectomy may be required in Cushing's disease due to pituitary or ectopic ACTH secretion. Adenomas arise from the reticularis layer of the adrenal cortex, which rarely releases too much adrenal androgen and estrogen, may also develop and have an indication for adrenalectomy. Adrenal surgery can be performed by laparoscopic or open technique. Today, laparoscopic adrenalectomy is the gold standard treatment in selected patients. Laparoscopic adrenalectomy can be performed transperitoneally or retroperitoneoscopi- cally. Both approaches have their advantages and disadvantages. In the selection of the surgery type, the experience and habits of the surgeon are also important, along with the patient’s characteristics. The most common type of surgery performed in the world is laparoscopic transabdominal lateral adrenalectomy, which most surgeons are more familiar with.
    [Show full text]
  • Cellular and Humoral Immune Alterations in Thymectomized Patients for Thymoma
    Cellular and humoral immune alterations in thymectomized patients for thymoma Maurizio Lalle, Mauro Minellli, Paola Tarantini, Mirella Marino, Virna Cerasoli, Francesco Facciolo, Cesare Iani, Mauro Antimi To cite this version: Maurizio Lalle, Mauro Minellli, Paola Tarantini, Mirella Marino, Virna Cerasoli, et al.. Cellular and humoral immune alterations in thymectomized patients for thymoma. Annals of Hematology, Springer Verlag, 2009, 88 (9), pp.847-853. 10.1007/s00277-008-0693-3. hal-00535026 HAL Id: hal-00535026 https://hal.archives-ouvertes.fr/hal-00535026 Submitted on 11 Nov 2010 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Ann Hematol (2009) 88:847–853 DOI 10.1007/s00277-008-0693-3 ORIGINAL ARTICLE Cellular and humoral immune alterations in thymectomized patients for thymoma Maurizio Lalle & Mauro Minellli & Paola Tarantini & Mirella Marino & Virna Cerasoli & Francesco Facciolo & Cesare Iani & Mauro Antimi Received: 1 September 2008 /Accepted: 23 December 2008 /Published online: 23 January 2009 # Springer-Verlag 2009 Abstract The aim of this study was to analyze the impact studies, a longer surveillance and a cooperative approach, of thymectomy on kinetics of the immune reconstitution in due to the rarity of the disease, are necessary to define thymoma patients.
    [Show full text]
  • Psi Technical Specs V31.Pdf
    AHRQ Quality Indicators Patient Safety Indicators: Technical Specifications Department of Health and Human Services Agency for Healthcare Research and Quality http://www.qualityindicators.ahrq.gov March 2003 Version 3.1 (March 12, 2007) AHRQ Quality Indicators Web Site: http://www.qualityindicators.ahrq.gov Table of Contents About the Patient Safety Indicators ............................................................................................................... 1 Patient Safety Indicators – Detailed Definitions ............................................................................................ 3 Complications of Anesthesia (PSI 1) ............................................................................................................ 3 Death in Low-Mortality DRGs (PSI 2) ........................................................................................................... 5 Decubitus Ulcer (PSI 3) ................................................................................................................................. 7 Failure to Rescue (PSI 4) .............................................................................................................................. 9 Foreign Body Left during Procedure, Secondary Diagnosis Field (PSI 5 and 21)...................................... 17 Iatrogenic Pneumothorax, Secondary Diagnosis Field (PSI 6 and 22)....................................................... 18 Selected Infections Due to Medical Care, Secondary Diagnosis Field (PSI 7 and 23) .............................
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • What's New in End Ocrine Surgery?
    What’s new in endocrine surgery? Endocrine surgery has become a well-defined part of general surgery. EUGENIO PANIERI, FCS(SA) Head, Oncology Endocrine Surgery, Department of Surgery, University of Cape Town Eugenio Panieri is a graduate of the University of Cape Town, and is Head of the Endocrine and Surgical Oncology Unit at Groote Schuur Hospital. His main areas of interest are in minimally access surgery for endocrine conditions, and the use of sentinel lymph node biopsy and immediate reconstruction in breast cancer. Endocrine surgery has steadily evolved from relative obscurity into a well-defined subdiscipline of general surgery. Success in this area relies on close co-operation with endocrinologists, radiologists, nuclear physicians, and pathologists. Endocrine surgeons have a pivotal role in the management of nodular thyroid disease and thyroid cancer, hyperparathyroidism, as well as functional adrenal and pancreatic tumours. Unlike other solid tumours, endocrine neoplasms make their presence known by systemic effects of excess hormone production, rather than by local symptoms related to tumour size or local invasion. As laboratory diagnostic methods and radiology imaging techniques have improved, so the demand for surgical expertise in this area has increased. Techniques of minimally invasive surgery have transformed the practice of general surgery. In some cases, such as cholecystectomy or anti-reflux surgery, laparoscopy has become the unquestioned standard of care; in others, such as hernia or colorectal surgery the debate continues. In this article I will describe the role such Fig. 1. CT scan of the abdomen illustrating a 7 cm phaeochromocytoma techniques have to play in the surgical management of endocrine in the left adrenal gland.
    [Show full text]